Unipolar Depression: Clinical Trials

9 trials for Unipolar Depression, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

9 completed. 9 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 29Completed 9
Phase 32Completed 2

Follow Unipolar Depression: new trials by email Literature Review of Unipolar Depression trials Research Report on Unipolar Depression

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Erythropoietin on Cognition and Neural Activity in Mood Disorders
Erythropoietin, Saline - Bipolar Disorder, Cognitive Impairment
Phase 2CompletedLars Vedel Kessing1032017-07-052023-03-16
Effects of Erythropoietin for Cognitive Side-effects of ECT
Erythropoietin, Saline - ECT, Cognitive Impairment
Phase 2CompletedMartin Balslev Jørgensen602017-06-262023-09-21
ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
electroconvulsive therapy (ECT), Ketamine - Treatment Resistant Depression, Electroconvulsive Therapy
Phase 2 / Phase 3CompletedBo Hu4032017-04-072023-09-28
Improve: Integrating Emotion Focused Components Into Psychological Therapy
Psychological therapy (PT) as TAU with integrated emotion focused components (TAU - EFT), Psychological therapy (PT) as TAU with focus on self-regulation (TAU - SR) - Unipolar Depression, Anxiety Disorder
Phase 2CompletedUniversity of Bern1042015-04-012019-09-10
tDCS as an add-on Treatment for Resistant Major Depression in Uni- or Bipolar Patients
transcranial Direct Current Stimulation (tDCS) (Eldith DC NeuroConn Stimulator) - Resistant Depression, Moods Disorders
Phase 2CompletedCentre Hospitalier Universitaire de Besancon872012-07-192023-06-06
Investigating tDCS as a Treatment for Unipolar and Bipolar Depression
Sham tDCS device, Soterix tDCS device - Unipolar Depression, Bipolar Depression
Phase 2 / Phase 3CompletedThe University of New South Wales1202012-06-012015-12-02
RCT of Psychoeducational Program of Depression
Control with depression course (CWD) - Unipolar Depression
Phase 2CompletedNorwegian Institute of Public Health1552001-03-012022-04-06
Antidepressant Treatment of Mexican-Americans: UCLA Pharmacogenetics and Pharmacogenomics Research Group
fluoxetine or desipramine - Major Depressive Disorder, Major Depression
Phase 2CompletedNational Institute of General Medical Sciences (NIGMS)7001999-11-012008-10-10
Evaluation of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Mood Disorders
Magstim Super Rapid Magnetic Stimulator, Cadwell MES-10 - Bipolar Disorder, Mood Disorder
Phase 2CompletedNational Institute of Mental Health (NIMH)911996-05-012006-07-13

Narrower conditions

Depressive Disorder (9)  ·  Bipolar Disorder (5)  ·  Depression (5)  ·  Cognitive Dysfunction (2)  ·  Depressive Disorder, Major (2)  ·  Mood Disorders (2)  ·  Adjustment Disorders (1)  ·  Anxiety Disorders (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Mania (1)  ·  Mental Disorders (1)

Broader conditions

Mental Disorders (8)  ·  Mood Disorders (7)  ·  Behavior (5)  ·  Behavioral Symptoms (5)  ·  Bipolar and Related Disorders (5)  ·  Cognition Disorders (2)  ·  Neurocognitive Disorders (2)  ·  Nervous System Diseases (1)  ·  Neurobehavioral Manifestations (1)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)  ·  Trauma and Stressor Related Disorders (1)

Interventions

Epoetin Alfa (2)  ·  Erythropoietin (2)  ·  Sodium Chloride (2)  ·  Desipramine (1)  ·  Electroconvulsive Therapy (1)  ·  Fluoxetine (1)  ·  Ketamine (1)  ·  Transcranial Direct Current Stimulation (1)

Sponsors

Bo Hu (1)  ·  Centre Hospitalier Universitaire de Besancon (1)  ·  Lars Vedel Kessing (1)  ·  Martin Balslev Jørgensen (1)  ·  National Institute of General Medical Sciences (NIGMS) (1)  ·  National Institute of Mental Health (NIMH) (1)  ·  Norwegian Institute of Public Health (1)  ·  The University of New South Wales (1)  ·  University of Bern (1)

Countries

United States (4)  ·  Denmark (2)  ·  Australia (1)  ·  France (1)  ·  Norway (1)  ·  Switzerland (1)

Top investigators

Kamilla W. Miskowiak, Prof. (2)  ·  Amit Anand, MD (1)  ·  Franz Caspar, Prof. PhD (1)  ·  Julio Licinio, MD (1)  ·  Lars V. Kessing, Prof. (1)  ·  Odd Steffen Dalgard, M.D., Ph.D. (1)

Results publications

PMID 15365580, PMID 19414708, PMID 25220861, PMID 26578205, PMID 27881113, PMID 29111077, PMID 29673379, PMID 30172724, PMID 30400939, PMID 30572160, PMID 33128939, PMID 37224232, PMID 38128460, PMID 38519416, PMID 40900112

NIH funding

2016 (2)